• Akebia Therapeutics granted 7 newly hired employees stock options covering 208,800 common shares on April 30, 2026.
• Exercise price set at $1.38 per share, matching closing price on grant date.
• Options vest over four years, with 25% vesting on first anniversary of grant date, remainder vesting quarterly.
• Each option carries a 10-year term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605041605PRIMZONEFULLFEED9712640) on May 04, 2026, and is solely responsible for the information contained therein.